BrightSpring Health Services filings document the operating results, governance, capital structure and material events of a public home- and community-based healthcare services company. Its 8-K reports include quarterly financial results, preliminary financial information, completed asset dispositions, underwriting agreements, secondary common stock offerings, company share repurchases and related registration-statement disclosures.
The company’s proxy materials cover annual meeting matters, director and governance disclosures, executive compensation and shareholder voting topics. BrightSpring filings also identify its Nasdaq-listed common stock under BTSG and its 6.75% Tangible Equity Units under BTSGU, providing formal disclosure around both operating performance and security structure.
BrightSpring Health Services, Inc. (BTSG) is the issuer in an amended ownership report by T. Rowe Price Associates, Inc., which lists 8,348,412 shares of common stock, or 4.2% of the class, as beneficially owned as of September 30, 2026. The report lists sole voting power over 8,189,940 shares and sole dispositive power over 8,348,412 shares, with shared voting and dispositive power of zero. T. Rowe Price Associates states that the report is not an admission of beneficial ownership and expressly denies beneficial ownership.
BrightSpring Health Services, Inc. reports that Executive Vice President, Chief Legal Officer and Secretary Jeffrey A. Hopper directly holds 42,295 common shares, including 16,294 restricted stock units (RSUs). Each RSU is a contingent right to receive one common share upon settlement. He also holds options for 15,547 common shares at an exercise price of $41.77 and 22,431 shares at $60.30. Both option grants vest in three equal annual installments beginning January 25, 2027, and expire on March 5, 2036, and September 14, 2036, respectively.
BrightSpring Health Services, Inc. (BTSG) is the subject of an ownership amendment reporting that FMR LLC and Abigail P. Johnson each beneficially owned 16,989,525 shares, or 8.6% of the class. FMR LLC reported sole voting power over 16,956,979 shares and sole dispositive power over 16,989,525 shares. Abigail P. Johnson reported no voting power and sole dispositive power over 16,989,525 shares.
BrightSpring Health Services, Inc. (BTSG) is the subject of an amended ownership report from Vanguard Portfolio Management, which reported beneficial ownership of 9,050,005 common shares, or 4.57%, as of September 30, 2026. The report states sole dispositive power over 9,050,005 shares and sole voting power over 160,655 shares; shared dispositive and voting power are each zero.
The reported ownership includes securities held by Vanguard funds and client accounts over which Vanguard Portfolio Management or specified affiliates exercise dispositive and/or voting power. Vanguard stated that it and managed investment companies and accounts have the right to receive or direct dividends or sale proceeds; no other person's interest exceeds 5%. The amendment was signed by My Trieu-Gatt, Authorized Signatory, Head of Global Fund Administration.
BrightSpring Health Services, Inc. (BTSG) reported third-quarter revenue of $4,213.2 million, compared with $3,334.1 million in the prior-year quarter. Net income attributable to BrightSpring was $100.1 million versus $55.8 million, and operating income was $160.5 million versus $87.8 million. For the first nine months of 2026, net cash provided by operating activities was $371.2 million, compared with $258.6 million in the same 2025 period.
The company completed the sale of its Community Living business on March 30, 2026, receiving $810.9 million in cash proceeds and recording a $101.8 million pre-tax gain. On May 28, 2026, it used $300.0 million of sale proceeds to repay Tranche B-5 debt and refinanced the remaining balance through a new Tranche B-6 loan; total debt was $2,237.6 million as of September 30, 2026. The company also repurchased $120.0 million of common stock during the first nine months. In the Amedisys and LHC Branches acquisition, branches in 17 states had been acquired; closing of the remaining three branches was expected in fiscal 2026, subject to customary regulatory approvals and other closing conditions.
BrightSpring Health Services, Inc. (BTSG) reported third-quarter 2026 revenue of $4.213234 billion, compared with $3.334106 billion for the quarter ended September 30, 2025. Income from continuing operations was $100.802 million, versus $37.488 million. Adjusted EBITDA, a non-GAAP measure, was $227.759 million, up 42% from $160.443 million.
BrightSpring increased full-year 2026 revenue guidance to $15,900 million to $16,125 million and Adjusted EBITDA guidance to $850 million to $860 million. The ranges represent revenue growth of 23.2% to 24.9% and Adjusted EBITDA growth of 37.6% to 39.3% compared with full-year 2025 results excluding Community Living. The guidance also excludes the effects of future closed acquisitions.
Operating cash flow was $204.322 million, compared with $107.936 million in Q3 2025. Pharmacy Solutions dispensed 10,949,875 prescriptions versus 10,793,219 a year earlier, while Home Health Care average daily census was 47,256 versus 29,980. The Amedisys and LHC branches acquisition is expected to contribute approximately $35 million in 2026 Adjusted EBITDA.
BrightSpring Health Services, Inc. (BTSG) reported that Chairman, President and Chief Executive Officer Jon B. Rousseau had 36,355 common shares withheld on October 25, 2026, to satisfy withholding taxes tied to vesting of 125,012 restricted stock units. The net settlement price was $60.11 per share, equal to the closing stock price on October 23, 2026; no Rule 10b5-1 plan is reported.
After the transaction, his reported direct holdings were 1,101,829 shares. The Rousseau Family Trust held 369,763 shares indirectly; Rousseau disclaimed beneficial ownership except to the extent of his pecuniary interest.
BrightSpring Health Services, Inc. (BTSG) officer Scott A. Greenwell, President, PharMerica, reported option-related transactions on September 14, 2026 made under a Rule 10b5-1 trading plan. He exercised stock options for 11,973 shares of common stock at an exercise price of $22.27 per share and then sold 15,099 shares of common stock at $57.91 per share in a sale reported as an open market or private transaction. Following the exercise, he held 23,947 stock options directly, with those options vesting in three equal annual installments commencing on June 20, 2026.
BrightSpring Health Services, Inc. (BTSG) officer Scott A. Greenwell has filed a notice under Rule 144 indicating an intention to sell up to 15,099 shares of BrightSpring common stock through Fidelity Brokerage Services LLC. The filing lists an approximate aggregate market value of $874,383.09 for the proposed sale, with NASDAQ as the trading market.
The shares to be sold consist of 3,126 shares originating from restricted stock that vested on June 20, 2026 and 11,973 shares issuable upon stock option exercise on September 14, 2026, with those options to be exercised for cash. The proposed sale date referenced is September 14, 2026.
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 13,678,154.97 shares of BrightSpring Health Services Inc. common stock, representing 7.0% of the class as of June 30, 2026. FMR LLC reports sole dispositive power over all 13,678,154.97 shares and sole voting power over 13,655,611.55 shares, with no shared voting or dispositive power.
Abigail P. Johnson is reported as having sole dispositive power over the same 13,678,154.97 shares, but no sole or shared voting power. The filing notes that one or more other persons may have rights to receive dividends or sale proceeds on these shares, but no such person holds more than 5% of the outstanding common stock.